StreptAvax: IDBE began enrollment of its Canadian Phase II trial of StreptAvax in 70 volunteers. An additional 20 volunteers will be given a marketed hepatitis

ID Biomedical Corp. (IDBE; TSE:IDB), Vancouver, B.C.
Product:

Read the full 88 word article

How to gain access

Continue reading with a
two-week free trial.